Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Chimeric Therapeutics Limited has announced the successful passage of all resolutions in their Extraordinary General Meeting, with a detailed breakdown of votes showing strong support for the proposed company directions. Shareholders voted on various resolutions, including the ratification of prior issues of advisor options and shares, with significant majorities in favor across all items. The company’s update highlights shareholder confidence and paves the way for the company’s future initiatives.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.
